U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06393881) titled 'A Study to Compare and Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of UI059 and UIC202201' on April 28.
Brief Summary: A randomized, open-label, multiple-dose crossover phase 1 clinical trial to compare and evaluate the safety, pharmacokinetics and pharmacodynamics characteristics after oral administration of UI059 and UIC202201 in healthy adult volunteers
Study Type: Interventional
Condition: Gastro-Intestinal Disorder
Intervention: * Drug: UI059
take UI059 once a day for 7 days
Other Name: Test
* Drug: UIC202201
take UIC202201 once a day for 7 days
Other Name: Reference
Recruitment Status: Not Yet Recruiting...